{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:48:31Z","timestamp":1767772111852,"version":"build-2065373602"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.gtc.2021.12.014","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T08:36:28Z","timestamp":1651048588000},"page":"425-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Crohn's Disease of the Elderly"],"prefix":"10.1016","volume":"51","author":[{"given":"Simon J.","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Galati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seymour","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gtc.2021.12.014_bib1","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/MIB.0000000000000738","article-title":"Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age-an increasing distinct entity?","volume":"22","author":"Jeuring","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.gtc.2021.12.014_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/gutjnl-2012-303864","article-title":"Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study","volume":"63","author":"Charpentier","year":"2014","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gtc.2021.12.014_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ecco-jcc\/jjaa181","article-title":"Epidemiology and natural history of elderly-onset inflammatory bowel disease: results from a territory-wide Hong Kong IBD Registry","volume":"15","author":"Mak","year":"2021","journal-title":"J\u00a0Crohns Colitis"},{"issue":"5","key":"10.1016\/j.gtc.2021.12.014_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/apt.14494","article-title":"Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case-control study","volume":"47","author":"Ma\u00f1osa","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.dld.2012.09.005","article-title":"Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD)","volume":"45","author":"Gower-Rousseau","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.gtc.2021.12.014_bib6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/ecco-jcc\/jjw054","article-title":"Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease","volume":"10","author":"Ananthakrishnan","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"issue":"7","key":"10.1016\/j.gtc.2021.12.014_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/MIB.0000000000001115","article-title":"Inflammatory bowel disease is similar in patients with older onset and younger onset","volume":"23","author":"Kochar","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.gtc.2021.12.014_bib8","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.cgh.2020.02.048","article-title":"Progression of elderly onset inflammatory bowel diseases: a systematic review and meta-analysis of population-based cohort studies","volume":"18","author":"Rozich","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2021.12.014_bib9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.gtc.2021.12.014_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/DCR.0000000000000274","article-title":"Genetic determinants associated with early age of diagnosis of IBD","volume":"58","author":"Connelly","year":"2015","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.gtc.2021.12.014_bib11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.mayocp.2020.04.018","article-title":"Introduction to thematic reviews on aging and geriatric medicine","volume":"95","author":"Pignolo","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib12","first-page":"3","article-title":"T\u00a0cell memory: the effect of ageing on CD8(+) T\u00a0cells","volume":"14","author":"Kugelberg","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.gtc.2021.12.014_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tem.2016.09.005","article-title":"Inflammaging and \u201cGarb-aging\u201d","volume":"28","author":"Franceschi","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.gtc.2021.12.014_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0105-2896.2005.00276.x","article-title":"Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling","volume":"205","author":"Cambier","year":"2005","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.gtc.2021.12.014_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000228558","article-title":"The microbiota in inflammatory bowel disease in different age groups","volume":"27","author":"Cucchiara","year":"2009","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11357-011-9217-5","article-title":"Aging of the human metaorganism: the microbial counterpart","volume":"34","author":"Biagi","year":"2012","journal-title":"Age (Dordr)"},{"issue":"6","key":"10.1016\/j.gtc.2021.12.014_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ecco-jcc\/jjv059","article-title":"Inflammatory bowel disease and the elderly: a review","volume":"9","author":"Taleban","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.arr.2009.10.004","article-title":"Human intestinal microbiota and healthy ageing","volume":"9","author":"Tiihonen","year":"2010","journal-title":"Ageing Res Rev"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib19","article-title":"A\u00a0review of frailty syndrome and its physical, cognitive and emotional domains in the elderly","volume":"2","author":"Khezrian","year":"2017","journal-title":"Geriatrics (Basel)"},{"key":"10.1016\/j.gtc.2021.12.014_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/RMHP.S168750","article-title":"Frailty syndrome: implications and challenges for health care policy","volume":"12","author":"Kojima","year":"2019","journal-title":"Risk ManagHealthc Policy"},{"issue":"9868","key":"10.1016\/j.gtc.2021.12.014_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11938-019-00254-1","article-title":"Special considerations for colorectal surgery in the elderly IBD patient","volume":"17","author":"Lightner","year":"2019","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"10","key":"10.1016\/j.gtc.2021.12.014_bib23","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1128\/AEM.71.10.6438-6442.2005","article-title":"Fecal microbiota composition and frailty","volume":"71","author":"van Tongeren","year":"2005","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"10.1016\/j.gtc.2021.12.014_bib24","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/ecco-jcc\/jjz082","article-title":"Systematic review: components of a comprehensive geriatric assessment in inflammatory bowel disease-a potentially promising but often neglected risk stratification","volume":"13","author":"Asscher","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"issue":"Suppl_1","key":"10.1016\/j.gtc.2021.12.014_bib25","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1093\/ecco-jcc\/jjx180.859","article-title":"P732 disability in older IBD patients","volume":"12","author":"Asscher","year":"2018","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"key":"10.1016\/j.gtc.2021.12.014_bib26","article-title":"Deficits in geriatric assessment associate with disease activity and -burden in older patients with inflammatory bowel disease","volume":"19","author":"Asscher","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2021.12.014_bib27","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1053\/j.gastro.2020.02.032","article-title":"Pretreatment frailty is independently associated with increased risk of infections after immunosuppression in patients with inflammatory bowel diseases","volume":"158","author":"Kochar","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/apt.15821","article-title":"Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases","volume":"52","author":"Kochar","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2021.12.014_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-020-06746-w","article-title":"Increasing prevalence of frailty and its association with readmission and mortality among hospitalized patients with IBD","author":"Faye","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.gtc.2021.12.014_bib30","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cgh.2020.08.010","article-title":"Frailty is independently associated with mortality and readmission in hospitalized patients with inflammatory bowel diseases","volume":"19","author":"Qian","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2021.12.014_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jamda.2016.01.019","article-title":"A\u00a0multicomponent exercise intervention that reverses frailty and improves cognition, emotion, and social networking in the community-dwelling frail elderly: a randomized clinical trial","volume":"17","author":"Tarazona-Santabalbina","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"11","key":"10.1016\/j.gtc.2021.12.014_bib32","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.amjmed.2015.06.017","article-title":"Nutritional, physical, cognitive, and combination interventions and frailty reversal among older adults: a randomized controlled trial","volume":"128","author":"Ng","year":"2015","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.gtc.2021.12.014_bib33","doi-asserted-by":"crossref","first-page":"e0190071","DOI":"10.1371\/journal.pone.0190071","article-title":"Interventions to improve the outcomes of frail people having surgery: a systematic review","volume":"12","author":"McIsaac","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12871-019-0880-x","article-title":"Routine frailty assessment predicts postoperative complications in elderly patients across surgical disciplines - a retrospective observational study","volume":"19","author":"Birkelbach","year":"2019","journal-title":"BMC Anesthesiol"},{"issue":"7","key":"10.1016\/j.gtc.2021.12.014_bib35","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00268-019-04950-y","article-title":"Prehabilitation before major abdominal surgery: a systematic review and meta-analysis","volume":"43","author":"Hughes","year":"2019","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.gtc.2021.12.014_bib36","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.dld.2016.07.012","article-title":"Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: a population-based study based on the National Health Insurance Fund database","volume":"48","author":"Kurti","year":"2016","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.gtc.2021.12.014_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/j.gastro.2017.10.034","article-title":"Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden","volume":"154","author":"Everhov","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib38","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/MEG.0000000000001047","article-title":"Prevalence and drug treatment practices of inflammatory bowel diseases in Poland in the years 2012-2014: an analysis of nationwide databases","volume":"30","author":"Holko","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn\u2019s disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2021.12.014_bib40","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1053\/j.gastro.2004.03.016","article-title":"5-Aminosalicylic acids and the risk of renal disease: a large British epidemiologic study","volume":"126","author":"Van Staa","year":"2004","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.gtc.2021.12.014_bib41","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.cgh.2019.10.043","article-title":"Inflammatory bowel diseases are associated with an increased risk for chronic kidney disease, which decreases with age","volume":"18","author":"Vajravelu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib42","first-page":"CD003715","article-title":"Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn\u2019s disease","author":"Akobeng","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.gtc.2021.12.014_bib43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0025-7125(16)30102-X","article-title":"Inflammatory bowel disease in older patients","volume":"78","author":"Fleischer","year":"1994","journal-title":"Med Clin North Am"},{"issue":"9","key":"10.1016\/j.gtc.2021.12.014_bib44","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s10620-012-2083-x","article-title":"Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity","volume":"57","author":"Juneja","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.gtc.2021.12.014_bib45","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREATTM registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.gtc.2021.12.014_bib46","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ajg.2014.313","article-title":"Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases","volume":"109","author":"Brassard","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"30","key":"10.1016\/j.gtc.2021.12.014_bib47","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.3748\/wjg.v25.i30.4158","article-title":"Elderly patients with inflammatory bowel disease: updated review of the therapeutic landscape","volume":"25","author":"LeBlanc","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gtc.2021.12.014_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/gutjnl-2012-304258","article-title":"Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study","volume":"63","author":"Travis","year":"2014","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.gtc.2021.12.014_bib49","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJM199409293311304","article-title":"A\u00a0comparison of budesonide with prednisolone for active Crohn\u2019s disease","volume":"331","author":"Rutgeerts","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib50","first-page":"248","article-title":"A\u00a0comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease","volume":"36","author":"Levine","year":"2003","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.gtc.2021.12.014_bib51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2036.1998.00321.x","article-title":"Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn\u2019s disease","volume":"12","author":"D\u2019Haens","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.gtc.2021.12.014_bib52","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.dld.2018.04.011","article-title":"Impact of age at diagnosis on natural history of patients with elderly-onset ulcerative colitis: a French population-based study","volume":"50","author":"Duricova","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","author":"Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gtc.2021.12.014_bib54","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cgh.2014.02.026","article-title":"Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease","volume":"12","author":"Lopez","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2021.12.014_bib55","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2011.06.050","article-title":"Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease","volume":"141","author":"Peyrin-Biroulet","year":"2011","journal-title":"Gastroenterology"},{"issue":"9701","key":"10.1016\/j.gtc.2021.12.014_bib56","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.gtc.2021.12.014_bib57","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease","volume":"318","author":"Lemaitre","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.14309\/ajg.0000000000001058","article-title":"Incidence of acute myeloid leukemia and myelodysplastic syndrome in patients with inflammatory bowel disease and the impact of thiopurines on their risk","volume":"116","author":"Khan","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.gtc.2021.12.014_bib59","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1053\/j.gastro.2021.04.022","article-title":"AGA Clinical Practice Guidelines on the medical management of moderate to severe luminal and perianal fistulizing Crohn\u2019s disease","volume":"160","author":"Feuerstein","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib60","first-page":"CD006884","article-title":"Methotrexate for maintenance of remission in Crohn\u2019s disease","author":"Patel","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/jgh.12015","article-title":"Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review","volume":"28","author":"Subramaniam","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.gtc.2021.12.014_bib62","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3899\/jrheum.130738","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"41","author":"Shea","year":"2014","journal-title":"J\u00a0Rheumatol"},{"issue":"5 Suppl 61","key":"10.1016\/j.gtc.2021.12.014_bib63","first-page":"S85","article-title":"Use of MTX in the elderly and in patients with compromised renal function","volume":"28","author":"Morgacheva","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.gtc.2021.12.014_bib64","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3899\/jrheum.090153","article-title":"Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review","volume":"37","author":"Bourr\u00e9","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib65","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/apt.13294","article-title":"Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease","volume":"42","author":"Lobat\u00f3n","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.gtc.2021.12.014_bib66","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/apt.15177","article-title":"Comparative safety and effectiveness of tumor necrosis factor \u03b1 antagonists and vedolizumab in elderly IBD patients: a multicentre study","volume":"49","author":"Adar","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib67","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ibd.23026","article-title":"Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease","volume":"19","author":"Desai","year":"2013","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cgh.2010.09.026","article-title":"Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease","volume":"9","author":"Cottone","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2021.12.014_bib69","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1053\/j.gastro.2020.03.071","article-title":"Age is just a number-frailty associates with outcomes of patients with inflammatory bowel disease","volume":"158","author":"Faye","year":"2020","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.gtc.2021.12.014_bib70","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1001\/jama.2014.5613","article-title":"Association between tumor necrosis factor-\u03b1 antagonists and risk of cancer in patients with inflammatory bowel disease","volume":"311","author":"Nyboe Andersen","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.gtc.2021.12.014_bib71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/apt.12624","article-title":"Systematic review with meta-analysis: malignancies with anti-tumour necrosis factor-\u03b1 therapy in inflammatory bowel disease","volume":"39","author":"Williams","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib72","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2013.441","article-title":"Drug therapies and the risk of malignancy in Crohn\u2019s disease: results from the TREATTM Registry","volume":"109","author":"Lichtenstein","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gtc.2021.12.014_bib73","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn\u2019s disease: a meta-analysis","volume":"7","author":"Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib74","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cgh.2015.07.037","article-title":"Risk of new or recurrent cancer in patients with inflammatory bowel disease and previous cancer exposed to immunosuppressive and anti-tumor necrosis factor agents","volume":"14","author":"Axelrad","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2021.12.014_bib75","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.gtc.2021.12.014_bib76","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib77","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s12325-016-0467-6","article-title":"Efficacy and safety of vedolizumab in ulcerative colitis and crohn\u2019s disease patients stratified by age","volume":"34","author":"Yajnik","year":"2017","journal-title":"Adv Ther"},{"issue":"9","key":"10.1016\/j.gtc.2021.12.014_bib78","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/2050640620951400","article-title":"Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study","volume":"8","author":"Cohen","year":"2020","journal-title":"United Eur Gastroenterol J"},{"issue":"20","key":"10.1016\/j.gtc.2021.12.014_bib79","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2021.12.014_bib80","article-title":"Real-World effectiveness and safety of ustekinumab in elderly Crohn\u2019s disease patients","author":"Garg","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.gtc.2021.12.014_bib81","doi-asserted-by":"crossref","first-page":"S560","DOI":"10.1016\/S0016-5085(21)02036-9","article-title":"Sa580 real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn\u2019s disease","volume":"160","author":"Garg","year":"2021","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1016\/j.gtc.2021.12.014_bib82","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","article-title":"Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis","volume":"376","author":"Papp","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"10148","key":"10.1016\/j.gtc.2021.12.014_bib83","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(18)31713-6","article-title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","volume":"392","author":"Gordon","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.gtc.2021.12.014_bib84","first-page":"2546161","author":"Bai","year":"2019","journal-title":"J\u00a0Immunol Res"},{"issue":"8","key":"10.1016\/j.gtc.2021.12.014_bib85","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1053\/j.gastro.2020.01.047","article-title":"Efficacy and safety of upadacitinib in a randomized trial of patients with crohn\u2019s disease","volume":"158","author":"Sandborn","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gtc.2021.12.014_bib86","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S2468-1253(20)30188-6","article-title":"Ozanimod induction therapy for patients with moderate to severe Crohn\u2019s disease: a single-arm, phase 2, prospective observer-blinded endpoint study","volume":"5","author":"Feagan","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.gtc.2021.12.014_bib87","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.gtc.2021.12.014_bib88","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jgs.16472","article-title":"COVID-19 and older adults: what we know","volume":"68","author":"Shahid","year":"2020","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"17","key":"10.1016\/j.gtc.2021.12.014_bib89","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2021.12.014_bib90","doi-asserted-by":"crossref","first-page":"m1443","DOI":"10.1136\/bmj.m1443","article-title":"Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang Province, China, January-March 2020: retrospective cohort study","volume":"369","author":"Zheng","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.gtc.2021.12.014_bib91","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/gutjnl-2020-321269","article-title":"COVID-19 and immunomodulation in IBD","volume":"69","author":"Neurath","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib92","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1053\/j.gastro.2020.06.003","article-title":"Risk of severe coronavirus disease 2019 in patients with inflammatory bowel disease in the United States: a multicenter research network study","volume":"159","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib93","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.14309\/01.ajg.0000704916.59012.8d","article-title":"S0717 Inflammatory bowel disease is not associated with severe outcomes of COVID -19: a cohort study from the United States epicenter","volume":"115","author":"Hong","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gtc.2021.12.014_bib94","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1053\/j.gastro.2020.05.065","article-title":"Impact of anti-tumor necrosis factor and thiopurine medications on the development of COVID-19 in patients with inflammatory bowel disease: a nationwide Veterans Administration Cohort Study","volume":"159","author":"Khan","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2021.12.014_bib95","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.gtc.2021.12.014_bib96","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1016\/S0016-5085(21)01514-6","article-title":"Fr493 Disease activity is associated with Covid-19 outcomes in IBD patients with effect modification by age","volume":"160","author":"Ricciuto","year":"2021","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gtc.2021.12.014_bib97","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s40520-021-01917-9","article-title":"Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease","volume":"33","author":"Calafat","year":"2021","journal-title":"Aging Clin Exp Res"},{"issue":"11","key":"10.1016\/j.gtc.2021.12.014_bib98","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/jgh.15191","article-title":"Incidence of SARS-CoV-2 infection in inflammatory bowel disease","volume":"35","author":"Lee","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.gtc.2021.12.014_bib99","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ibd\/izaa162","article-title":"From the American epicenter: coronavirus disease 2019 in patients with inflammatory bowel disease in the New York City metropolitan area","volume":"27","author":"Axelrad","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.gtc.2021.12.014_bib100","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41467-017-00923-8","article-title":"Global hotspots and correlates of emerging zoonotic diseases","volume":"8","author":"Allen","year":"2017","journal-title":"Nat Commun"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855321007536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855321007536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:22Z","timestamp":1760179282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855321007536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0889855321007536"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2021.12.014","relation":{},"ISSN":["0889-8553"],"issn-type":[{"type":"print","value":"0889-8553"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crohn's Disease of the Elderly","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2021.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}